Article Details

Eisai Data at ASCO 2021 Highlight Breadth of Oncology Portfolio Across Various Tumor Types

Retrieved on: 2021-05-17 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Eisai Data at ASCO 2021 Highlight Breadth of Oncology Portfolio Across Various Tumor Types. View article details on hiswai:

Excerpt

Key analyses on the lenvatinib plus pembrolizumab combination include a poster on the primary analysis of the health-related quality of life (HRQoL) ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up